124 related articles for article (PubMed ID: 31805373)
1. Found in translation: The rationale behind the early development of glibenclamide in large hemispheric infarction.
Jacobson SM; MacAllister TW; Geliebter DM
Neurosci Lett; 2020 Jan; 716():134672. PubMed ID: 31805373
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial.
Sheth KN; Elm JJ; Molyneaux BJ; Hinson H; Beslow LA; Sze GK; Ostwaldt AC; Del Zoppo GJ; Simard JM; Jacobson S; Kimberly WT
Lancet Neurol; 2016 Oct; 15(11):1160-9. PubMed ID: 27567243
[TBL] [Abstract][Full Text] [Related]
3. Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date.
King ZA; Sheth KN; Kimberly WT; Simard JM
Drug Des Devel Ther; 2018; 12():2539-2552. PubMed ID: 30147301
[TBL] [Abstract][Full Text] [Related]
4. Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design.
Sheth KN; Elm JJ; Beslow LA; Sze GK; Kimberly WT
Neurocrit Care; 2016 Feb; 24(1):132-9. PubMed ID: 26268138
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis.
Sheth KN; Petersen NH; Cheung K; Elm JJ; Hinson HE; Molyneaux BJ; Beslow LA; Sze GK; Simard JM; Kimberly WT
Stroke; 2018 Jun; 49(6):1457-1463. PubMed ID: 29789393
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Glibenclamide Reduces Lesional Water Uptake in Large Hemispheric Infarction.
Vorasayan P; Bevers MB; Beslow LA; Sze G; Molyneaux BJ; Hinson HE; Simard JM; von Kummer R; Sheth KN; Kimberly WT
Stroke; 2019 Nov; 50(11):3021-3027. PubMed ID: 31537189
[TBL] [Abstract][Full Text] [Related]
7. Glibenclamide in cerebral ischemia and stroke.
Simard JM; Sheth KN; Kimberly WT; Stern BJ; del Zoppo GJ; Jacobson S; Gerzanich V
Neurocrit Care; 2014 Apr; 20(2):319-33. PubMed ID: 24132564
[TBL] [Abstract][Full Text] [Related]
8. [Elevated intracranial pressure following brain infarction--therapeutical possibilities].
Bovim G; Johnsen HJ; Zwart JA; Unsgård G
Tidsskr Nor Laegeforen; 1995 Jan; 115(2):207-9. PubMed ID: 7855811
[TBL] [Abstract][Full Text] [Related]
9. Osmotherapy for malignant cerebral edema in a phase 2 prospective, double blind, randomized, placebo-controlled study of IV glibenclamide.
Hinson HE; Sun E; Molyneaux BJ; von Kummer R; Demchuk A; Romero J; Taylor Kimberly W; Sheth KN
J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104916. PubMed ID: 32414580
[TBL] [Abstract][Full Text] [Related]
10. Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model.
Shuaib A; Xu Wang C; Yang T; Noor R
Stroke; 2002 Dec; 33(12):3033-7. PubMed ID: 12468809
[TBL] [Abstract][Full Text] [Related]
11. Brain damage related to hemorrhagic transformation following cerebral ischemia and the role of K ATP channels.
Yang Y; Zhang XJ; Yin J; Li LT
Brain Res; 2008 Nov; 1241():168-75. PubMed ID: 18817754
[TBL] [Abstract][Full Text] [Related]
12. Glyburide is associated with attenuated vasogenic edema in stroke patients.
Kimberly WT; Battey TW; Pham L; Wu O; Yoo AJ; Furie KL; Singhal AB; Elm JJ; Stern BJ; Sheth KN
Neurocrit Care; 2014 Apr; 20(2):193-201. PubMed ID: 24072459
[TBL] [Abstract][Full Text] [Related]
13. Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema.
Austinat M; Braeuninger S; Pesquero JB; Brede M; Bader M; Stoll G; Renné T; Kleinschnitz C
Stroke; 2009 Jan; 40(1):285-93. PubMed ID: 18988906
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis.
Dong MX; Hu QC; Shen P; Pan JX; Wei YD; Liu YY; Ren YF; Liang ZH; Wang HY; Zhao LB; Xie P
PLoS One; 2016; 11(7):e0158848. PubMed ID: 27387385
[TBL] [Abstract][Full Text] [Related]
15. [Follow-up monitoring with magnetic resonance tomography after decompressive trephining in experimental "malignant" hemispheric infarct].
Engelhorn T; Dörfler A; Egelhof T; Schwab S; Heiland S; Sartor K; Forsting M
Zentralbl Neurochir; 1998; 59(3):157-65. PubMed ID: 9816666
[TBL] [Abstract][Full Text] [Related]
16. Aggressive decompressive surgery in patients with massive hemispheric embolic cerebral infarction associated with severe brain swelling.
Mori K; Aoki A; Yamamoto T; Horinaka N; Maeda M
Acta Neurochir (Wien); 2001; 143(5):483-91; discussion 491-2. PubMed ID: 11482699
[TBL] [Abstract][Full Text] [Related]
17. Effect of glycerol on ischemic cerebral edema assessed by magnetic resonance imaging.
Sakamaki M; Igarashi H; Nishiyama Y; Hagiwara H; Ando J; Chishiki T; Curran BC; Katayama Y
J Neurol Sci; 2003 May; 209(1-2):69-74. PubMed ID: 12686405
[TBL] [Abstract][Full Text] [Related]
18. Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats.
Belayev L; Busto R; Zhao W; Clemens JA; Ginsberg MD
J Neurosurg; 1997 Oct; 87(4):595-601. PubMed ID: 9322848
[TBL] [Abstract][Full Text] [Related]
19. BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema.
Pergakis M; Badjatia N; Chaturvedi S; Cronin CA; Kimberly WT; Sheth KN; Simard JM
Expert Opin Investig Drugs; 2019 Dec; 28(12):1031-1040. PubMed ID: 31623469
[No Abstract] [Full Text] [Related]
20. Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial.
Kimberly WT; Bevers MB; von Kummer R; Demchuk AM; Romero JM; Elm JJ; Hinson HE; Molyneaux BJ; Simard JM; Sheth KN
Neurology; 2018 Dec; 91(23):e2163-e2169. PubMed ID: 30446594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
